India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Why is sex and reproductive education important for adolescents? Many adolescents are afraid of where to go, how to get services, whether there will be confidentiality, and whether their families will find out Why is sex and reproductive education important for adolescents? 16-year-old Sandhya Rai had consensual sex and was forced to have an unsafe abortion after becoming pregnant. Unwanted pregnancies and health problems are increasing due to lack of access to sex education and reproductive health services for adolescents in Nepal. 16-year-old ‘Sandhya Rai’ (name changed) was a 10th grader. She fell in love with a young man in grade 11 at the same school she attended. Both dreamed of getting married after completing their studies. One day, they went to Nagarkot to celebrate the young man’s birthday and stayed there. They had consensual sex. A few months later, Sandhya realized that her menstruation had stopped. After she told her mother, a test was done at the hospital. She was ...